vimarsana.com

Latest Breaking News On - Ron kurtz - Page 2 : vimarsana.com

RxSight, Inc (NASDAQ:RXST) Q4 2023 Earnings Call Transcript

RxSight, Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-0.36.

United statesRobbie marcusSteven lichtmanOliver moravcevicShelley thunenRon kurtzExchange commissionRxsight incAmerican society of cataractCall transcript februaryRxsight fourth quarterRxsight presidentChief executive officerChief financial officerLight adjustable lensInvestor relations

RxSight Inc (RXST) Reports Significant Revenue Growth in Q4 and Full Year 2023

Robust Sales Drive 78% Quarterly and 82% Annual Revenue Increases

Ron kurtzRxsight incFinancial performanceInsight incPresident ron kurtz

RxSight, Inc Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance

ALISO VIEJO, Calif., Jan. 07, 2024 RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today.

Oliver moravcevicShelleyb thunenRon kurtzRxsight incExchange commissionUnaudited fourth quarterDelivery devicesAdjustable lensesChief executive officerLight adjustable lensRxsight light adjustableRxsight light delivery deviceRisk factorsQuarterly reportRelations contact

RxSight, Inc Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and

ALISO VIEJO, Calif., Jan. 07, 2024 (GLOBE NEWSWIRE) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced certain

Shelleyb thunenRon kurtzOliver moravcevicExchange commissionRxsight incUnaudited fourth quarterDelivery devicesAdjustable lensesChief executive officerLight adjustable lensRxsight light adjustable lensRxsight light delivery deviceRisk factorsQuarterly reportRelations contactNation world

RxSight, Inc Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance

ALISO VIEJO, Calif., Jan. 07, 2024 RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today.

Shelleyb thunenRon kurtzOliver moravcevicExchange commissionRxsight incGlobenewswire incUnaudited fourth quarterDelivery devicesAdjustable lensesChief executive officerLight adjustable lensRxsight light adjustableRxsight light delivery deviceRisk factorsQuarterly reportRelations contact

vimarsana © 2020. All Rights Reserved.